Mitochondrial Dna Depletion Syndrome 14 (cardioencephalomyopathic Type); Mtdps14
Genes related to Mitochondrial Dna Depletion Syndrome 14 (cardioencephalomyopathic Type); Mtdps14
- OPA1
Clinical Features
Top most frequent phenotypes and symptoms related to Mitochondrial Dna Depletion Syndrome 14 (cardioencephalomyopathic Type); Mtdps14
- Generalized hypotonia
- Hearing impairment
- Sensorineural hearing impairment
- Feeding difficulties
- Skeletal muscle atrophy
- Optic atrophy
- Cardiomyopathy
- Hypertonia
- Hypertrophic cardiomyopathy
- Muscular hypotonia of the trunk
And another 10 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Mitochondrial Dna Depletion Syndrome 14 (cardioencephalomyopathic Type); Mtdps14 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
OPA1 Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
OPA1
Specificity
100 %
Genes
100 % |
OPA1 Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
OPA1
Specificity
100 %
Genes
100 % |
OPA1 Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
OPA1
Specificity
100 %
Genes
100 % |
mtDNA Depletion/Integrity Panel (MitomeNGS).
By Baylor Miraca Genetics Laboratories (United States).
SLC25A4, SUCLA2, SUCLG1, SUCLG2, TWNK, TK2, MGME1, RRM2B, DGUOK, TYMP, MPV17, OPA1, OPA3, POLG, POLG2
Specificity
7 %
Genes
100 % |
PEO Panel (MitomeNGS).
By Baylor Miraca Genetics Laboratories (United States).
SLC25A4, TWNK, MGME1, RRM2B, OPA1, OPA3, POLG, POLG2
Specificity
13 %
Genes
100 % |
OPA1 DNA Sequencing Test (Related to mtDNA depletion).
By Athena Diagnostics Inc (United States).
OPA1
Specificity
100 %
Genes
100 % |
Progressive External Ophthalmoplegia Evaluation (POLG, TWINKLE, ANT1, OPA1, MELAS).
By Athena Diagnostics Inc (United States).
SLC25A4, TWNK, MT-TL1, OPA1, POLG
Specificity
20 %
Genes
100 % |
You can get up to 99 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like KNOBLOCH SYNDROME 1; KNO1 CYSTATHIONINURIA HYPERLIPOPROTEINEMIA, TYPE V HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA HEPATOERYTHROPOIETIC PORPHYRIA MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C HERMANSKY-PUDLAK SYNDROME 10; HPS10